13.02.2013 Views

Physics And Chemistry Basis Of Biotechnology - De Cuyper - tiera.ru

Physics And Chemistry Basis Of Biotechnology - De Cuyper - tiera.ru

Physics And Chemistry Basis Of Biotechnology - De Cuyper - tiera.ru

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

J.W.M. Bulte and L.H. Bryant Jr.<br />

be detected without refocusing of 180° pulses (T2* effect). <strong>Of</strong> paramount importance<br />

here is that water protons at distant sites can be affected, leading to a “blooming effect”,<br />

i.e. an amplification of signal changes.<br />

Magnetite particles need to be stabilised in order to prevent aggregation. Most<br />

commonly this is accomplished by a coating of dextran. Immunoglobulins can then be<br />

covalently linked to the polysaccharide coat using a periodate-oxidation/borohydridereduction<br />

method, which, through the formation of Schiff bases as intermediates,<br />

covalently links the amine (lysine) groups of the mab to the alcohol groups of the<br />

dextran [36,37]. MION-(46L) iron oxide nanoparticles have been conjugated this way<br />

to polyclonal IgG for detection of induced inflammation [38), to mab fragments for the<br />

specific visualisation of cardiac infarct [39], and to intact mabs for immunospecific<br />

detection of intracranial small cell lung carcinoma [40], ICAM- 1 gene expression [4 1],<br />

and oligodendrocyte progenitors [42]. Alternative ways of attaching mabs to magnetic<br />

nanoparticles include glutaraldehyde crosslinking [43], complexing through ultrasonic<br />

sonication [44,45], using the biotin-streptavidin system [46] and amine-sulfhydryl<br />

group linkage [47,48]. For in vivo applications, limited success (e.g. t<strong>ru</strong>e specific<br />

immunodetection) has been achieved thus far but this is likely to improve with the<br />

development of smaller nanoparticles that facilitate endothelial penetration and exhibit<br />

longer blood half-lives.<br />

3. Other magnetically labelled ligands<br />

Either paramagnetic chelates or magnetic nanoparticles can be linked to molecules<br />

other than mabs in order to confer specificity for a targetable receptor. For the group of<br />

paramagnetic agents, it has been demonstrated that “folated” gadolinium-dendrimers<br />

can be targeted in vitro to folate-receptor bearing leukaemic cells [32], and induce<br />

significant specific changes in relaxation times that is inhibitable by free, nonconjugated<br />

folate. This may be used for in vivo imaging of folate-receptor<br />

overexpressing tumours [49], but further work including the use of non-targeted<br />

polymer controls is needed. Another approach of conferring specificity to a<br />

paramagnetic label is to link it to an antisense oligonucleotide; a specific proton<br />

relaxation enhancement has been achieved for 5S rRNA as a macromolecular target and<br />

its labelled complimentary 6mer antisense sequence [50].<br />

For magnetic iron oxide particles, the first use of a targetable ligand employed the<br />

use of arabinogalactan [51,52] in lieu of bacterial dextran as the polysaccharide<br />

coating: in this way, specific uptake in hepatocytes is achieved through uptake of the<br />

asialoglycoprotein receptor. Similar results were obtained when asialofetuin was used<br />

as a coating [53], and may be useful for improved detection of hepatocellular<br />

carcinoma. (Synthetic) peptides can also be linked to MION-46 or other very small iron<br />

oxide particles. For instance, cholecystokinin- [54] and secretin-[55] linked particles<br />

have been employed for MR visualisation of their respective pancreatic receptor and<br />

may aid in the diagnosis of pancreatic cancer. Transferrin is another example of a<br />

targetable protein, since certain tumours are known to overexpress transferrin receptors.<br />

Transferrin-iron oxide particles have been used for specific detection of gliosarcoma<br />

200

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!